Scientalab

Founded in 2021 in Paris, Scienta Lab is a company specialising in the application of artificial intelligence to research and development in immunology and inflammation. The company created EVA, an AI model designed to support biopharmaceutical players in their decisions throughout the R&D process. In 2025, Scienta Lab joined the EIC Accelerator programme, the European Union’s benchmark scheme for disruptive technologies.